25 of the Best Rheumatologists Near Me in halethorpe, MD

Marc Hochberg is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Hochberg is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Arthritis, Osteoporosis, Rheumatoid Arthritis (RA), Kienbock's Disease, and Knee Replacement. Dr. Hochberg is board certified in American Board Of Internal Medicine - Internal Medicine, 1976 and American Board Of Internal Medicine - Rheumatology, 1978. Dr. Hochberg is currently accepting new patients.

Marcela Ferrada is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Ferrada is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Relapsing Polychondritis, VEXAS Syndrome, MAGIC Syndrome, and Vasculitis. Dr. Ferrada is board certified in American Board Of Internal Medicine - Critical Care Medicine, 2016 and American Board Of Internal Medicine - Rheumatology, 2018. Dr. Ferrada is currently accepting new patients.

Omer Pamuk is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Pamuk is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Ankylosing Spondylitis, and Adult Still's Disease. Dr. Pamuk is board certified in American Board Of Internal Medicine - Internal Medicine, 2025. Dr. Pamuk is currently accepting new patients.

Dr. Philip Seo is an Associate Professor in the Division of Rheumatology. A graduate of Harvard College and the College of Physicians and Surgeons at Columbia University, Dr. Seo completed his Internal Medicine training as a member of the Osler Medical Service at the Johns Hopkins Hospital. Since then, he has worked at Johns Hopkins in several capacities, including as a hospitalist at Johns Hopkins Bayview Medical Center, and as an Assistant Chief of Service of the Department of Medicine at the Johns Hopkins Hospital, before joining the Division of Rheumatology. Dr. Seo is the Director of the Johns Hopkins Vasculitis Center and Director of the Johns Hopkins Rheumatology Fellowship Program. His clinical interests lie in the assessment and treatment of patients with systemic vasculitis, in particular, the ANCA-associated vasculitides, which include granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis. Dr. Seo is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, Takayasu Arteritis, and Tissue Biopsy. Dr. Seo is board certified in American Board Of Internal Medicine. Dr. Seo is currently accepting new patients.

Michelle Petri, M.D. is a Professor of Medicine at the Johns Hopkins University School of Medicine. She attended medical school at Harvard University and fulfilled her internal medicine residency at the Massachusetts General Hospital. In addition, she completed two fellowship programs at the University of California, San Francisco in allergy and immunology and rheumatology. Dr. Petri is the Director of the Hopkins Lupus Cohort, a longitudinal study of morbidity and mortality in systemic lupus erythematosus, and Co-Director of the Hopkins Lupus Pregnancy Center. Dr. Petri is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome, and Cutaneous Lupus Erythematosus (CLE). Dr. Petri is board certified in American Board Of Allergy And Immunology and American Board Of Internal Medicine. Dr. Petri is currently accepting new patients.

Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California. She completed rheumatology fellowship at Johns Hopkins and joined the faculty in 2013. She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma or overlap myositis. She also has a special interest in novel therapeutics in refractory dermatomyositis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Paik is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Polymyositis, Myositis, and Scleroderma. Dr. Paik is board certified in American Board Of Internal Medicine. Dr. Paik is currently accepting new patients.

Dr. Alan Baer graduated from the Johns Hopkins University School of Medicine in 1978 and completed his post-graduate medical training in Internal Medicine and Rheumatology at the Johns Hopkins and Vanderbilt University Hospitals. He was a faculty member at the University at Buffalo, State University of New York, from 1986 to 2007, and served there as Chief of the Section of Rheumatology and Fellowship Program Director. He joined the faculty at Johns Hopkins in 2007 and is currently Professor of Medicine and Director of the Jerome L. Greene Sjogren's Syndrome Center. Since 2015, he has been an Investigator in the Sjogren's Syndrome Clinic at the National Institutes of Health. He was Chief of Rheumatology and Clinical Director of the Johns Hopkins University Rheumatology Practice at the Good Samaritan Hospital in Baltimore, Maryland from 2007 to 2014. Dr. Baer is currently engaged in a number of research studies in the area of Sjogren's syndrome, both at Johns Hopkins and in the NIH Sjogren's Syndrome Clinic. He was the principal investigator of the NIH subcontract to Johns Hopkins to conduct the Sjogren's International Registry (SICCA) and enrolled 300 patients into the registry. The SICCA registry has been a rich source of clinical data and biospecimens for research that Dr. Baer is conducting with colleagues at both Hopkins and the University of California-San Francisco. He is conducting a longitudinal observational study of patients with Sjogren's syndrome. Dr. Baer is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Sjogren Syndrome, Rheumatoid Arthritis (RA), Arthritis, and Interstitial Keratitis. Dr. Baer is board certified in American Board Of Internal Medicine. Dr. Baer is currently accepting new patients.

Dr. Christopher-Stine is the Co-Founder and Director of the Johns Hopkins Myositis Center. She is a Professor of Medicine and Neurology. She is a longstanding core faculty member of the Johns Hopkins University School of Medicine College Advisory Program and serves as the Co-Chair of the Johns Hopkins Institutional Review Board (IRB 5). Dr. Christopher-Stine graduated Cum Laude with a B.A. in chemistry from Franklin and Marshall College; was elected to Alpha Omega Alpha at Hahnemann University School of Medicine, where she received her MD degree, and she attained her Masters of Public Health degree from the Johns Hopkins Bloomberg School of Public Health. Her internship and residency training were completed at MCP Hahnemann University, where she also served as Chief Resident. She pursued her rheumatology fellowship training at Johns Hopkins. Dr. Christopher is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Myositis, Polymyositis, Dermatomyositis, and Inclusion Body Myositis. Dr. Christopher is board certified in American Board Of Internal Medicine. Dr. Christopher is currently accepting new patients.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Scleromyxedema, and Eosinophilic Fasciitis. Dr. Hummers is board certified in American Board Of Internal Medicine. Dr. Hummers is currently accepting new patients.

Dr. Christopher A. Mecoli is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is rheumatology. A physician-scientist, Dr. Mecoli serves on the faculty of Johns Hopkins Myositis Center and Johns Hopkins Scleroderma Center. He earned his M.D. from Rutgers New Jersey Medical School. He completed an internal medicine residency at the Hospital of the University of Pennsylvania and a rheumatology fellowship at Johns Hopkins. He also holds an M.H.S. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Mecoli is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Dermatomyositis, Myositis, Polymyositis, and Scleroderma. Dr. Mecoli is currently accepting new patients.

Dr. Wigley received his M.D. degree from the University of Florida College of Medicine. He completed an internship and residency at Johns Hopkins where he also trained in a postdoctoral fellowship program. Dr. Wigley is a physician-scientist whose specialty is Raynaud’s phenomenon and scleroderma. He founded The Johns Hopkins Scleroderma Center with Robert A. Wise, M.D., of the Johns Hopkins Division of Pulmonary Medicine. Dr. Wigley has been honored with two American College of Rheumatology awards over the past couple years. He received the ACR Distinguished Clinician Scholar Award in 2009 and the ACR Masters Award in 2011. Dr. Wigley is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma. Dr. Wigley is board certified in American Board Of Internal Medicine. Dr. Wigley is currently accepting new patients.

Dr. Ana-Maria Orbai is an Associate Professor of Medicine in the Division of Rheumatology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and psoriatic arthritis. Dr. Orbai earned her M.D. from the Iuliu Hatieganu School of Medicine and Pharmacy, Cluj-Napoca, in Romania. She completed internship and residency training in internal medicine at the Johns Hopkins University-Sinai Hospital program. Subsequently, Dr. Orbai completed her post-doctoral fellowship training in rheumatology at Johns Hopkins. During her fellowship she earned her Master in Health Sciences degree in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Orbai directs the Psoriatic Arthritis Program in the Johns Hopkins Arthritis Center. Her clinical focus is psoriatic arthritis and spodyloarthritis. Dr. Orbai's research aims to understand psoriatic disease subtypes and improve treatment strategies for people with psoriatic arthritis. Dr. Orbai was awarded a Rheumatology Research Foundation Scientist Development award in 2014 and a Jerome L Greene Foundation Scholar award in 2018. Dr. Orbai is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Psoriatic Arthritis, Psoriasis, Arthritis, and Rheumatoid Arthritis (RA). Dr. Orbai is board certified in American Board Of Internal Medicine. Dr. Orbai is currently accepting new patients.

Andrea Fava is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Fava is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Scleroderma, and Systemic Sclerosis (SSc). Dr. Fava is board certified in American Board Of Internal Medicine. Dr. Fava is currently accepting new patients.

Nasser Nasseri-Asl is a Rheumatologist practicing medicine in Catonsville, Maryland. Dr. Nasseri-Asl is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Eosinophilia-Myalgia Syndrome, Antisynthetase Syndrome, Rheumatoid Arthritis (RA), and Undifferentiated Connective Tissue Disease (UCTD). Dr. Nasseri-Asl is board certified in The American Board Of Internal Medicine - Rheumatology. Dr. Nasseri-Asl is currently accepting new patients.

Jamal Mikdashi is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Mikdashi is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Sarcoidosis, Systemic Lupus Erythematosus (SLE), Neurosarcoidosis, and Cutaneous Lupus Erythematosus (CLE). Dr. Mikdashi is board certified in American Board Of Internal Medicine - Rheumatology, 1992. Dr. Mikdashi is currently accepting new patients.

Dr. Grader-Beck is an Associate Professor of Clinical Medicine in the Rheumatology Division. Dr. Grader-Beck’s clinical expertise includes the diagnosis and treatment of Sjogren's syndrome as well as inflammatory arthritis. He has a specific interest in improving quality of patient care and clinical research using state of the art information technology. He is developing innovative ways in how clinicians and researchers can leverage electronic health record systems to deliver individualized patient care and precision medicine. Dr. Grader-Beck is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Sjogren Syndrome, Rheumatoid Arthritis (RA), Interstitial Keratitis, and Dermatomyositis. Dr. Grader-Beck is board certified in American Board Of Preventive Medicine and American Board Of Internal Medicine. Dr. Grader-Beck is currently accepting new patients.

Violeta Rus is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Rus is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Lupus Nephritis, Systemic Lupus Erythematosus (SLE), and Undifferentiated Connective Tissue Disease (UCTD). Dr. Rus is board certified in American Board Of Internal Medicine - Rheumatology, 1998. Dr. Rus is currently accepting new patients.

Dr. Hellmann is one of Johns Hopkins best physicians, teachers, and program builders. He holds the Aliki Perroti endowed Chair, recognizing his leadership in education. Dr. Hellmann’s clinical care and research focus is on vasculitis. Over the last four years, Dr. Hellmann has evaluated over 200 patients with systemic vasculitis. Areas of interest have included granulomatosis with polyangiitis, temporal arteritis, Takayasu’s arteritis, and polyarteritis nodosa. Dr. Hellmann is director of the Johns Hopkins Center for Innovative Medicine which promotes patient-centered care through the creative collaboration of research, teaching, and patient care programs. Dr. Hellmann is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Behcet Disease, Necrotizing Vasculitis, Takayasu Arteritis, and Juvenile Temporal Arteritis. Dr. Hellmann is board certified in American Board Of Internal Medicine. Dr. Hellmann is currently accepting new patients.

Chair of Rheumatology at UM BWMC. Dr. Hertzman is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Osteoporosis, Postmenopausal Osteoporosis, Juvenile Primary Osteoporosis, and Gout. Dr. Hertzman is board certified in American Board Of Internal Medicine - Internal Medicine, 1983 and ABIM - Rheumatology - Rheumatology, 1986. Dr. Hertzman is currently accepting new patients.

Dr. Antiochos sees patients in the Division of Rheumatology on the Bayview campus and conducts basic science research into the pathogenesis of rheumatic diseases in the Division's laboratory. Lab website: Brendan Antiochos MD. Dr. Antiochos is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Granulomatosis with Polyangiitis, Necrotizing Vasculitis, Sjogren Syndrome, and Vasculitis. Dr. Antiochos is currently accepting new patients.

Dr. Laura Cappelli is an Associate Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and adverse effects from cancer immunotherapy. Dr. Cappelli earned her M.D. from Johns Hopkins. She completed her residency in internal medicine and performed a fellowship in rheumatology at the Johns Hopkins Hospital. She has a MHS in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Cappelli focuses on immune related adverse events due to cancer immunotherapy and all forms of inflammatory arthritis. She co-directs the Immune-related toxicity team which provides clinical, research and educational support for immune related adverse events. Her primary research interest is inflammatory arthritis due to immune checkpoint inhibitor therapy. She also studies rheumatoid arthritis. Dr. Cappelli is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Arthritis, Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, and Polymyalgia Rheumatica. Dr. Cappelli is board certified in American Board Of Internal Medicine. Dr. Cappelli is currently accepting new patients.

Dr. Albayda is an Associate Professor of Medicine in the Division of Rheumatology. She is the Director of the Rheumatology Fellowship Program, as well as Director of the Musculoskeletal Ultrasound and Injection Clinic. Nationally, she is involved in MSK Ultrasound education and has expertise in arthritis and inflammatory myopathies. Her research focuses on imaging biomarkers in rheumatic diseases, developing muscle ultrasound, clinical phenotypes in myositis, as well as longitudinal care and therapeutics in inclusion body myositis. Dr. Albayda is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Inclusion Body Myositis, Myositis, and Polymyositis. Dr. Albayda is board certified in American Board Of Internal Medicine. Dr. Albayda is currently accepting new patients.

Dr. Homa Timlin is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include systemic lupus erythematosus, and lupus nephritis. Dr. Timlin serves on the faculty of the Johns Hopkins Consultative Rheumatology Clinic. A member of the Royal College of Physicians, Dr. Timlin earned her medical degree at Romania’s Universitatea de Medicana Si Farmacie Carol Davila. Upon completion of rheumatology fellowships, Oxford in the United Kingdom and an internal medicine residency in the United States, she joined the Johns Hopkins Lupus Center in 2011. After a one-year postdoctoral lupus fellowship under the mentorship of Dr. Michelle Petri, she finished her post-doctoral fellowship in rheumatology at Johns Hopkins. She also holds a master’s degree in clinical immunology (London University), MRCP diploma (Member of the Royal College of Physicians), Certificate of Completion of Specialty Training (CCST). Dr. Timlin has been an active educator who works with trainees at all levels, nationally and internationally, in the inpatient and outpatient settings. Presently, Dr. Timlin has established a retrospective cohort of several hundred patients with lupus and lupus nephritis, and site lead at the Johns Hopkins Bayview Medical Center. Dr. Timlin is the medical chair for the local chapter of Lupus Foundation of America (LFA) and the director of an IRB-approved prospective human diagnostic study using magnetic resonance imaging (MRI) to evaluate lupus nephritis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Timlin is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Discoid Lupus Erythematosus (DLE), and Cutaneous Lupus Erythematosus (CLE). Dr. Timlin is board certified in American Board Of Internal Medicine. Dr. Timlin is currently accepting new patients.

Dr. Ami Shah is an Associate Professor of Medicine and Director of the Division of Rheumatology at the Johns Hopkins University School of Medicine. Dr. Shah also serves as the Co-Director of the Johns Hopkins Scleroderma Center. Her areas of clinical expertise include rheumatology, particularly scleroderma and Raynaud's phenomenon. She is a graduate of the Massachusetts Institute of Technology and Johns Hopkins University School of Medicine. She completed her internal medicine residency training at Stanford University Hospital & Clinics and rheumatology post-doctoral fellowship at Johns Hopkins. During her fellowship training, she earned her Master of Health Science in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Shah’s clinical practice is focused on the broad spectrum of patients with scleroderma and related disorders, and her expertise includes management of complications such as Raynaud’s phenomenon, digital ischemia, pulmonary hypertension, cardiac dysfunction, myopathy, aggressive skin disease and concomitant cancer. Dr. Shah teaches post-doctoral fellows in her clinic about the evaluation and management of scleroderma. Dr. Shah’s research program has focused on the interface between cancer and autoimmunity in scleroderma, myositis and the newly emerging area of immune-related adverse events due to immune checkpoint inhibitor therapy. In highly collaborative studies, her group has published seminal observations linking cancer with the development of autoimmunity in scleroderma, with implications for cancer screening strategies in this population and the potential to shed insight into the pathogenesis of paraneoplastic rheumatic disease. In addition to her work in cancer and autoimmunity, Dr. Shah has an active research program in other clinical and therapeutic aspects of scleroderma, including early detection of cardiopulmonary complications and improving outcome measures and therapeutics for Raynaud's phenomenon. Dr. Shah also directs rheumatology precision medicine initiatives through the Johns Hopkins Individualized Health (inHealth) Initiative. The division’s program seeks to harness technological resources for comprehensive data collection and harmonization, strengthen novel data analytic approaches including defining unique patient subgroups, and accelerate the incorporation of discoveries into the delivery of clinical care. Dr. Shah has been a recipient of the ACR Research and Education Foundation Clinical Investigator Fellowship Award. In 2018, her research contributions were recognized at the 5th Systemic Sclerosis World Congress with receipt of the Edith Busch Prize for Young Investigators. In 2020, she was honored to receive the prestigious Henry Kunkel Young Investigator Award from the American College of Rheumatology. She is a member of the American College of Rheumatology. Dr. Shah is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Scleredema. Dr. Shah is board certified in American Board Of Internal Medicine. Dr. Shah is currently accepting new patients.

Dr. Allan Gelber is Professor of Medicine and Deputy Director for Education and Faculty Development in the Division of Rheumatology. He holds a joint appointment in the Department of Epidemiology at the Bloomberg School of Public Health and is Associate Faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research. Dr. Gelber is a graduate of the Johns Hopkins University School of Medicine and received both his MPH and PhD degrees (the latter in Clinical Investigation) at the Bloomberg School. He pursued internship and residency training in internal medicine at Duke University and then undertook his fellowship training in rheumatology at Johns Hopkins. Dr. Gelber has had an active role as an Educator in the Rheumatic Diseases. He previously served as Fellowship Program Director at Johns Hopkins from 2001-2011. Thereafter, he shifted his primary educational focus from rheumatology fellows to medical students, and to internal medicine housestaff on the Bayview and Johns Hopkins campuses. He directs the Musculoskeletal Section of the Genes-to-Society Course to the 2nd year medical school class. Currently, Dr. Gelber serves as Thayer Firm Faculty Leader of the Osler Medical Training Program. and among the Aliki Scholars at Johns Hopkins Bayview Medical Center. Dr. Gelber chairs the M.D. Admissions Committee at the School of Medicine. Dr. Gelber is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Gout, Arthritis, Scleroderma, Knee Replacement, and Endoscopy. Dr. Gelber is board certified in American Board Of Internal Medicine. Dr. Gelber is currently accepting new patients.